comparemela.com

Page 2 - George Milne News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AUPH Stock Soars As Aurinia Explores Strategic Alternatives, Including A Buyout

AUPH Stock Soars As Aurinia Explores Strategic Alternatives, Including A Buyout
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Bristol myers squibbGeorge milneJoseph haganDouglas miehmJoseph schwartzAurinia pharmaceuticalsWall streetSun pharmaceutical

Aurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

29.06.2023 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today announced that its Board of Directors has initiated an exploration of strategic alternatives. As part of this process, the Board will consider a wide range of options for .

United statesGeorge milneJoseph haganAurinia pharmaceuticals stockExchange commissionAurinia pharmaceuticalsKorn ferryAnnual report

Aurinia Pharma Shares Rise 19% After Move to Explore Strategic Alternatives

By Chris Wack Aurinia Pharmaceuticals shares were up 19% to $10.87 in premarket trading after the company said late Thursday that its board of directors has.

Joseph haganGeorge milneChris wackAurinia pharmaceuticalsJp morganKorn ferry

Aurinia Pharmaceuticals Share Surge Shows Investor Support for Board Reboot, Strategic Review

Aurinia Pharmaceuticals Share Surge Shows Investor Support for Board Reboot, Strategic Review
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

George milneJoseph haganAurinia pharmaceuticals

Aurinia Pharma Shares Rise 9% As Company Explores Strategic Alternatives

By Chris Wack Aurinia Pharmaceuticals shares were up 9% to $10.01 on Friday after the biopharmaceutical company said late Thursday that its board of.

Joseph haganGeorge milneChris wackJp morganAurinia pharmaceuticalsKorn ferryArticle normalBiotechnology servicesHealthcare life sciencesFinancial performanceShare price movement disruptionsBoard of directorsCorporate industrial newsEquity marketsCommodity financial market newsContent types

vimarsana © 2020. All Rights Reserved.